Twist Bioscience Corporation | Mid-cap | Healthcare
$35.59
-6.76%
| Twist Bioscience Stock Comparison:
Twist Bioscience vs Thermo FisherTwist Bioscience vs DanaherTwist Bioscience vs GrailTwist Bioscience vs Opko HealthTwist Bioscience vs NeogenTwist Bioscience vs S&P 500 | Market
Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 313.0M
Gross Profit 133.3M 42.61%
Operating Income -175.9M -56.20%
Net Income -208.7M -66.69%
EPS (Diluted) -$3.60

Balance Sheet Metrics

Total Assets 614.3M
Total Liabilities 141.6M
Shareholders Equity 472.7M
Debt to Equity 0.30

Cash Flow Metrics

Operating Cash Flow -121.7M
Free Cash Flow -69.2M

Revenue & Profitability Trend

Twist Bioscience Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue313.0M245.1M203.6M132.3M90.1M
Cost of Goods Sold179.6M155.4M119.3M80.6M61.4M
Gross Profit133.3M89.7M84.2M51.7M28.7M
Operating Expenses309.2M296.6M333.3M205.0M146.3M
Operating Income-175.9M-206.9M-249.0M-153.3M-117.6M
Pre-tax Income-208.2M-203.5M-228.3M-154.0M-139.5M
Income Tax560.0K1.2M-10.4M-1.9M382.0K
Net Income-208.7M-204.6M-217.9M-152.1M-139.9M
EPS (Diluted)-$3.60-$3.60-$4.04-$3.15-$3.57

Income Statement Trend

Twist Bioscience Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets346.8M424.3M596.5M546.5M334.9M
Non-Current Assets267.5M352.1M364.9M155.6M64.0M
Total Assets614.3M776.4M961.4M702.1M398.9M
Liabilities
Current Liabilities71.0M73.3M90.7M63.1M36.0M
Non-Current Liabilities70.6M79.6M81.3M58.2M26.6M
Total Liabilities141.6M153.0M172.0M121.3M62.6M
Equity
Total Shareholders Equity472.7M623.4M789.4M580.8M336.3M

Balance Sheet Composition

Twist Bioscience Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income-208.7M-204.6M-217.9M-152.1M-139.9M
Operating Cash Flow-121.7M-146.6M-119.5M-113.3M-135.7M
Investing Activities
Capital Expenditures-5.1M-27.8M-101.9M-27.1M-9.9M
Investing Cash Flow-3.1M50.6M-238.7M156.2M-114.6M
Financing Activities
Dividends Paid-----
Financing Cash Flow-4.0M-4.4M260.5M309.7M289.8M
Free Cash Flow-69.2M-170.3M-226.2M-139.3M-152.1M

Cash Flow Trend

Twist Bioscience Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) -9.85
Forward P/E -14.78
Price to Book 4.89
Price to Sales 6.19
PEG Ratio -14.78

Profitability Ratios

Profit Margin -54.98%
Operating Margin -44.79%
Return on Equity -38.22%
Return on Assets -15.04%

Financial Health

Current Ratio 4.51
Debt to Equity 18.25
Beta 2.37

Per Share Data

EPS (TTM) -$3.25
Book Value per Share $7.35
Revenue per Share $5.90

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
twst2.2B-9.854.89-38.22%-54.98%18.25
Thermo Fisher 152.5B23.693.0913.70%15.19%69.23
Danaher 140.5B37.982.767.22%15.81%34.56
Grail 1.5B-0.700.61-62.22%-62.12%2.67
Opko Health 1.0B-16.120.65-3.04%-5.66%37.58
Neogen 1.0B865.000.39-16.71%-53.56%33.61

Financial data is updated regularly. All figures are in the company's reporting currency.